Transient, human and murine decidua-associated, Natural Killer lymphocytes (uNK cells) have special, localized roles in early gestational endometrial remodeling and angiogenesis. To determine if uNK cells promote a specific vessel subtype, a histological time-course study of implantation site endothelia was undertaken using normal C57BL/6J (B6) and uNK-deficient B6.129-Rag2 tm1Fwa
INTRODUCTION
Uterine Natural Killer (uNK) cells are lymphocytes that differentiate in abundance during decidualization of mouse implantation sites and promote angiogenesis by production of placenta growth factor (PlGF), vascular endothelial cell growth factor (VEGF), and other angiogenic substances [1] [2] [3] . At midgestation (Gestation Day [gd] 11.5-12.5), a cell death program onsets and uNK cell numbers decline rapidly [4, 5] . In mice without lymphocytes (alymphoid B6.129-Rag2 tm1Fwa -Il2rg tm2Cgn ), implantation sites are edematous, have limited decidual differentiation, and lack normal structural modifications of the maternal spiral arterioles [6] . Engraftment of such mice with marrow that is deficient in the potential for B cell and T cell differentiation, followed by mating, has demonstrated that reconstitution by only NK cells restores complete decidual development and initiates spiral arterial modification [6, 7] . This is achieved through uNK cell production of interferon-gamma (IFNG) [8] .
In humans, endometrial decidualization is accompanied by the appearance of analogous CD56 bright uNK cells. CD56 bright uNK cells express PlGF and VEGFC [9] . VEGFC has the unique role of inducing lymphatic endothelial cell proliferation [10, 11] . CD56 bright uNK cells may contribute to the modification of human spiral arteries [12] , together with rapidly invading endovascular and intramural fetal trophoblast cells [13, 14] . Xenogeneic coengraftment of CD56 bright NK cells with human trophoblasts into T cell-deficient nude (Foxn1 mutant) mice showed that uterine but not blood CD56 bright NK cells recruit trophoblasts and promote angiogenesis in vivo [15] . Thus, CD56 bright uNK cells may draw endovascular and/or intramural trophoblast cells to spiral arteries. Invasion of vessel-associated trophoblasts is shallower in mice than in humans. In mice, endovascular and intramural trophoblast giant cells are recognized as separate lineages with distinct gene expression profiles [16] .
To address whether the edematous implantation sites of uNK-cell-deficient mice might reflect altered ratios in vessel subtypes, especially a reduction in lymphatics, we characterized endothelial cell subtypes in implantation sites from normal and alymphoid mice using immunohistochemistry. The endothelial cell tyrosine kinase system of Ephrin (EFN) ligands and EPH receptors was used to distinguish arterial (EFNB2 þ ) from venous (EPHB4 þ ) vessels [17] , and LYVE1 was used to identify lymphatics [18] . EFNB2 is a membrane-bound molecule that acts via close cell contact (up to 20 nm) to control not only arterial endothelial cell growth but also the motility and adhesion of vascular smooth muscle cells and pericytes to growing arterial endothelial cell tubes [19] . EPHB4 is the receptor for EFNB2 that binds specifically and at very high affinity due to a single receptor amino acid, Leu-95. EPHB4 expression occurs in veins of all diameters [20] , is implicated in tumor angiogenesis, and is considered a target for anti-angiogenic tumor therapy [21] . Since both EFNs and EPHs are receptor tyrosine kinases, ligation induces bidirectional signaling that is essential and specific for delineating arterial-venous boundaries [22] . For example, EFNB2 forward signaling through EPHB4 receptor inhibits cell adhesion, whereas EPHB4 reverse signaling to EFNB2 induces cell attachment [23] . EFNB2 expression is not necessarily developmentally programmed and can be controlled by postnatal local microenvironments [24] . We found that EFNB2 is strongly expressed by both uNK and trophoblast giant cells and that spiral arteries move from displaying an arterial
EFNB2
þ phenotype prior to modification to an EPHB4 þ phenotype during and after their gestational modification.
MATERIALS AND METHODS

Mice
B6 mice, purchased from The Jackson Laboratory (Bar Harbor, ME), were housed and bred under conventional husbandry at Queen's University. Alymphoid mice, dually deleted for recombinase activating gene-2 and common cytokine receptor chain gamma on a B6 background (B6.129-Rag2 tm1Fwa Il2rg tm2Cgn ), were bred under barrier husbandry at the University of Guelph. For timed mating, estrous females were selected, paired to males of the same genotype, and checked for a copulation plug the following morning. The morning of plug detection was named gd0.5. Two or more viable implantation sites from multiple (two to four) females were studied at each gd. One B6 (estrus) and one alymphoid (diestrus) uterus as well as B6 liver, kidney, and lung were also used as nongestational tissues to confirm antibody specificity. Archival tissue blocks [25] for three implantation sites from alymphoid mice receiving intravenous gd6 B6 splenocytes 96 h prior to euthanasia were also examined. All procedures were conducted under Animal Utilization Protocols that were approved by the Animal Care Committees of the two institutions.
Histological Procedures
Mice were deeply anesthetized then perfused with 30 ml of freshly prepared 4% paraformaldehyde in buffered saline (PFA). The liver, kidney, lung, and uterus were dissected, the pregnant uterus was transected between implantation sites, and all tissues were postfixed for 15 min in PFA, except for implantation sites older than gd10.5, which were postfixed for 60 min. Standard procedures were used for automated processing into paraffin and embedding. Sections were prepared at 7 lm. Serial sections were used when possible. For identification and enumeration of uNK cells, sections were stained with Dolichos biflorus agglutinin (DBA) lectin [26] . DBA þ uNK cells were enumerated in central regions of decidual basalis (DB) on four sections per implantation site using a 1-mm 2 ocular grid at 2003 magnification. Because large vascular areas are present in later decidua, the areas that represented blood vessel lumens were also measured and used as a factor to adjust the numbers of uNK cells to what would have been present in 1 mm 2 of tissue without major vessels. This calculated number was then compared for different days of gestation. All image analyses were performed by an AxioImager M.1 microscope and Axiovision software (Carl Zeiss, Oberkochen, Germany).
Immunohistochemistry for EFNB2, EPHB4, and LYVE1
To confirm EFNB2, EPHB4, and LYVE1 antibody specificity for blood vessel subtypes, sections of liver, kidney, lung, and uteri were examined. Briefly, after deparaffinization and rehydration, antigen was retrieved by immersion of slides in sodium citrate buffer (0.01 M, pH 6.0, 958C, 10 min). Peroxidases were inactivated (3% hydrogen peroxide in 0.1 M PBS, 6 min) and blocking reagent was then applied (1% BSA in PBS, 20 min) and replaced by primary antibodies (goat anti-mouse EFNB2, EPHB4, or LYVE1; all at 1:40 dilution; R&D Systems, MN) overnight at 48C. After rinsing, slides were incubated with secondary antibody (biotin-conjugated rabbit anti-goat IgG; 30 min; Vector Laboratories, CA) then treated with Extravidin-peroxidase (1:100; 30 min; Sigma, MO). After rinsing with PBS, slides were incubated in fresh 3,3 0 -Diaminobenzidine (2 min; Sigma), rinsed in tap water, counterstained with Harris hematoxylin, dried, and mounted with cover slips using Permount (Fisher Scientific, ON). Negative controls were corresponding sections of each block processed identically, except the primary antibody was replaced by buffer. Arteries, veins, and lymphatics could be distinguished by these reagents. These antibodies were then used in ;20 independent experiments to study implantation sites (gd6.5, 8.5, 10.5, and 12.5) in B6 and alymphoid mice. Six independent trials were conducted on archival tissue from alymphoid mice receiving splenocytes. Spiral arteries were identified by their mesometrial position and concentric layers of smooth-muscle cells, whereas venous and lymphatic vessels had limited smooth muscle association [27] .
Preparation of Cell Suspensions and Flow Cytometry
B6 mice (gd10.5) were used for flow cytometry using leukocytes isolated from spleen, liver, and decidua. To prepare decidua, the uterus was transected between implantation sites, and nonimplanted regions were discarded. From sites of attachment, fetal and placental tissues were removed and discarded, and the remaining myometrium was scraped with a razor blade to separate DB. To isolate leukocytes, tissue was minced into 1-mm 3 pieces with sterile scissors, dissociated by pressing through a stainless metal mesh into 0.1 M PBS, and transferred to tubes. Cells were pelleted by centrifugation (750 3 g), resuspended with PBS, loaded over a Lympholyte-M density gradient (CEDARLANE Laboratories Ltd., NC) and centrifuged (1350 3 g; 30 min; 208C). Cells were aspirated from the interface, harvested by centrifugation (1200 3 g), and washed twice with PBS. After incubation (30 min) in normal rat serum, leukocytes were stained (30 min, 48C) with rat anti-mouse pan-NK cells (DX5-FITC; 1 lg/ml), PE-Cy5-conjugated rat anti-mouse CD3 (145-2C11; 1.2 lg/ml; eBioscience, CA), and goat anti-EFNB2 (2 lg/ml). After rinsing, secondary porcine anti-goat IgG-PE (R&D Systems, Inc. MN) was added to recognize EFNB2 (30 min, 48C). Stained cells were analyzed (50 000 gated cells) by using a Cytomics FC500 Flow Cytometry (Beckman Coulter, Fullerton, CA), and the data were processed with FCS Express V3 software (DeNovo, Los Angeles, CA).
Statistical Analysis
Data were analyzed using one-way ANOVA of SPSS 13.0 (SPSS Inc., Chicago, IL). P , 0.05 was considered significant. All data are presented as mean 6 SD.
RESULTS
EFNB2, EPHB4, and LYVE1 Expression in Tissues from Nonpregnant Mice
While EFNB2 and EPHB4 have been widely considered specific markers for arteries and veins, it is becoming clear that these molecules are expressed by additional cell types [28, 29] . LYVE1 is very specific for lymphatic endothelium [18] . The vascular specificity of these reagents was confirmed in tissues with clear distinctions between vessel subtypes. These included liver, kidney, lung, and uterine wall with its associated mesentery (Supplemental Fig. 1 available online at www. biolreprod.org). In addition, the reactivity of these antibodies on virgin uterus was established (Supplemental Figs. 2 and 3 available online at www.biolreprod.org). EFNB2 was expressed by arteries and some lumen and glandular epithelia. EPHB4 was expressed by thin-walled vessels assumed to be venules, by lumen and glandular epithelia, and by scattered endometrial cells (Supplemental Fig. 2 available online at www.biolreprod.org). LYVE1 was expressed by small, thinwalled vessels located in the myometrium of both B6 and alymphoid mice and by scattered endometrial cells near uterine glands (Supplemental Fig. 3 available online at www. biolreprod.org). These data confirmed that the antibodies discriminated nonoverlapping vessel subtypes in mouse uterus.
Decidual Expression of EFNB2/EPHB4 in gd6.5-12.5 B6 Implantation Sites
Murine decidua was induced antimesometrially at each blastocyst implantation site ;gd4.0. Decidualization then progressed laterally and mesometrially over ;48 h. At gd6.5 in B6 mice, decidual EFNB2 reactivity ( Fig. 1A1 ) was more abundant and more randomly dispersed than EPHB4 reactivity (Fig. 1B1 , arrowhead) that appeared to associate with small nascent vessels. Unexpectedly, some uNK cells were EFNB2 þ (Fig. 1A1, arrow) , but none were EPHB4
þ . More EFNB2 þ and EPHB4 þ decidual stromal cells were present at gd8.5 than at gd6.5 ( Fig. 1, A-D) . Not-yet-modified uterine spiral arteries, identified by their muscle coats, were EFNB2 þ /EPHB4 À , with EFNB2 being expressed mainly by vascular smooth muscle cells (Fig. 1C1 ). UNK cells remained EFNB2 þ even as fully differentiated, heavily granulated, mature cells [26] that surrounded incoming branches of the uterine vessels at each implantation site (Fig. 1C1, arrow) . EFNB2 reactive uNK cells were also dotted throughout the transient mesometrial thickening of the uterine wall (mesome-
trial lymphoid aggregate of pregnancy [MLAp] , found from gd8.5 around entering arteries). In addition, a few uNK cells were weakly reactive for EPHB4 (Fig. 1D1, arrowhead) .
From gd10.5 in B6 mice, endometrial reactivity of EFNB2 and EPHB4 was most prominent on vessels and lymphocytes. The endothelia of the spiral arteries, which were now histologically modified, showed discontinuous reactivity for EFNB2. These vessels displayed patches of EPHB4 þ reactivity suggestive of a change in venous endothelial cell function (Fig. 1, E and F) . UNK cells, which reached their peak numbers by gd10.5, were intensely reactive for both EFNB2 and EPHB4. Indeed, both antigens appeared to be more strongly expressed by uNK cells than by spiral arterial endothelium (Fig. 1, E1 and F1, arrow) .
In gd12.5 B6 endometrium, remodeled, dilated spiral artery walls and uNK cells showed less EFNB2 expression than at gd10.5 (Fig. 1G) . Although EPHB4 expression in venules appeared to be stable, there was an obvious gain in EPHB4 reactivity over the entire wall circumference of spiral arteries (Fig. 1H ).
EFNB2/EPHB4 Expression in gd6.5-12.5 Alymphoid Implantation Sites
Endometrial stromal staining patterns for EFNB2 and EPHB4 in gd6.5 alymphoid decidua were similar to B6 except for the absence of EFNB2 þ lymphocytes caused by the genetic deletion of lymphocytes (Fig. 2, A and B) . Alymphoid decidua at gd8.5 was less organized than B6 decidua, as previously reported [7] , but its EFNB2 expression was more broadly distributed. Alymphoid spiral arteries, like those in B6, were unmodified EFNB2 þ /EPHB4 À vessels (Fig. 2, C and D) . By gd10.5, alymphoid implantation sites were distinctly different from those in B6. Only the former showed strong EFNB2 and EPHB4 reactivity over myometrial circular smooth muscle (compare Fig. 2 to Fig. 1) . In alymphoid mice, decidua basalis adjacent to the myometrium was particularly reactive for EPHB4 (Fig. 2F) . The unmodified spiral arteries, characteristic of midgestation alymphoid implantation sites, showed two molecular differences to gd10.5 B6. First, alymphoid spiral arteries were uniform in their expression of mural EFNB2 and, second, in contrast to B6, lacked any expression of EPHB4. In alymphoid mice, only venules were EPHB4 þ (Fig. 2, E and F) . At gd12.5, EFNB2 had become almost absent from most alymphoid decidual cell types, with some expression remaining in the undeveloped MLAp region [6] . The untransformed alymphoid spiral arteries had increased EFNB2 expression on mural cells (Fig. 2G ) and now showed de novo coexpression of endothelial EPHB4 (Fig. 2, G and H) . These arteries differed from those in gd12.5 B6 where EFNB2 levels in the vascular coat cells had dropped and the vascular smooth muscle cells, rather then the endothelium, were EPHB4 þ . As in B6, EPHB4 expression by decidual venules appeared stable (Fig. 2H) .
Decidual Expression of LYVE1 in gd6.5-12.5 B6 and Alymphoid Implantation Sites Decidual LYVE1 expression was detected in all B6 and alymphoid implantation sites from gd6.5 to 12.5. For both , and EPHB4 reactivity was localized to individual cells or very small vessels that appeared to be endothelial tubes (arrowheads, B1). At gd8.5, EFNB2 was largely localized to vessels recognized as arterial by their muscular coats (C1). Spiral arteries (SA) did not show any EPHB4 staining (D1). Reactive EFNB2 þ uNK cells (arrows, C1) were more abundant than EPHB4 þ uNK cells (arrowhead, D1). At gd10.5, weak EFNB2 staining remained on the now-modified SA walls (E), while uNK cells (arrows, E1) became the most reactive cells in the tissue (E, E1). EPHB4 was localized to uNK cells (arrow, F1) and to endothelium of SA, where its expression was discontinuous (F1). At gd12.5, EFNB2 reactivity continued to decline on smooth muscle cells of the modified SA and on uNK cells (arrows, G1), while both cell types showed significant EPHB4 reactivity (arrows, H1). EPHB4 reactivity was displayed by endothelial rather than muscular cells of SA and by endothelium in veins (V). L, residual uterine lumen; MLAp, mesometrial lymphoid aggregate of pregnancy, a transient uterine wall structure at mouse implantation sites; DB, decidual basalis. Bars ¼ 200 lm (A-H) and 50 lm (A1-H1).
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strains, well-developed lymphatic vessels were clearly distributed in the myometrium, where they were associated with spiral arteries and with veins between gd8.5 and 12.5.
Additional LYVE1
þ cells were scattered in decidua basalis (Fig. 3) . Much less LYVE1 reactivity was present in lymphatic vessels and endometrial cells at gd10.5 and 12.5 (not shown), and no significant differences were apparent between the strains that could be attributed to the absence of uNK cells.
EFNB2, EPHB4, and LYVE1 Expression Patterns on Trophoblasts During Mouse Pregnancy
Pregnancy-associated spiral artery modification is a complex event that involves trophoblasts. Dynamic changes in expression of EFNB2, EPHB4, and LYVE1 by B6 and alymphoid trophoblasts were seen in the implantation sites we examined (Figs. 3 and 4) . In B6 mice at gd6.5, abundant   FIG. 3 . LYVE1 immunohistochemistry of B6 and alymphoid implantation sites at gd6.5 (A, C) and gd8.5 (B, D). Boxed areas are presented as higher magnification images to the right of each panel. LYVE1-reactive cells are present in all images. At gd6.5, strong, diffuse staining (black arrow) was present near the conceptus and residual uterine lumen. Reactive single, small cells are present but rare in decidua basalis of both strains (A1, C1). At gd8.5, lymphatic vessels are clearly present within the uterine wall (myometrium; arrowhead) in both strains, and rare, single reactive cells remain in the DB (B, D). In B6 but not alymphoid mice, the diffuse, periconceptus stain has been lost (C vs. D). Trophoblast giant cells are reactive (white arrow, A2). There was little LYVE1 staining at gd10.5 or 12.5 (not shown). DB, decidual basalis; EC, ectoplacental cone; L, residual uterine lumen; M, mesometrial region. Bars ¼ 400 lm (A-D) and 100 lm (A1-D1 and A2-D2).
FIG. 2. Immunohistochemistry for EFNB2 (left panel) and EPHB4
(right panel) in gd6.5-12.5 of alymphoid implantation sites. Boxed areas in A-H are shown to the right of each image at higher magnification. At gd6.5, EFNB2 staining was more diffuse to individual cells (A1), and vascular structures appeared more developed with EPHB4 reactivity (arrowheads, B1). At gd8.5, EFNB2 was localized to arterial muscular coats (C1), and spiral arteries (SA) had no EPHB4 reactivity (D). Reactive EFNB2 þ stromal cells (white arrows, C1) and EPHB4 þ vessels (D1) were detected. At gd10.5, intense EFNB2 staining was found in the walls of the SA and in the deep stroma of the DB next to myometrium (arrowhead, E). This is normally a region rich in uNK cells, suggesting EFNB2 may be key to uNK cell positioning within implantation sites. EPHB4 was widely expressed in deep decidual stroma and weakly expressed on SA (F, F1). At gd12.5, EFNB2 reactivity remained strong on the smooth muscle cells of the SA (G, G1), but EPHB4 reactivity (H1) was also presented on SA endothelial cells. L, residual uterine lumen; MLAp, mesometrial lymphoid aggregate of pregnancy; DB, decidual basalis; V, vein. Bars ¼ 200 lm (A-H) and 50 lm (A1-H1).
EFNB2
þ trophoblast was found close to the core of the ectoplacental cone. There was less EPHB4 expression (Fig. 4 , A and E), and only giant cells expressed LYVE1 (Fig. 3A) . At gd8.5, EFNB2
þ and EPHB4 þ trophoblasts were identified along the lateral sinusoids of B6 mice (not shown), and LYVE1 expression had become reduced (Fig. 3B) . At gd10.5, some B6 trophoblasts continued to express EFNB2 þ and EPHB4 þ , with giant cells showing the strongest expression (Fig. 4, C and G) . By this time, there was no significant LYVE1 expression by giant or other B6 trophoblast cells. By gd12.5 only rare, weakly positive EFNB2 þ or EPHB4 þ B6 trophoblast individual giant cells were seen (not shown).
EFNB2/EPHB4 reactivity was very weak in gd6.5 alymphoid trophoblasts compared with B6 (Fig. 4, B and F) , but LYVE1 reactivity on giant cells appeared equivalent to that in B6 (Fig. 3, A and C) . At gd8.5, EFNB2
þ , EPHB4 þ (not shown), and LYVE1 þ (Fig. 3 , B and D) trophoblasts exhibited less expression than in B6. At gd10.5, alymphoid giant cells continued to weakly express EFNB2 þ , there was almost no detectable EPHB4 (Fig. 4, D and H) , and LYVE1 reactivity was absent (not shown). Alymphoid trophoblasts showed barely detectable reactivity with any of these markers by gd12.5 (not shown).
EFNB2/EPHB4 Expression in Alymphoid Mice with uNK Cells Reconstituted by B6 Splenocytes
Implantation sites at gd10.5 from alymphoid mice reconstituted 96 h earlier with B6 splenocytes contain uNK cells but at a much reduced abundance compared to normal implantation sites. This reconstitution protocol, however, effects spiral arterial modification. Compared with gd10.5 implantation sites from nonreconstituted alymphoid mice, those in B6-reconstituted mice showed a detectable decrease in the mesometrial stromal staining of EFNB2 and EPHB4 along the boundary between the MLAp and DB (Fig. 5, A and B) . EFNB2 expression on spiral arteries was drastically down-regulated and became limited almost exclusively to endothelial cells. Occasionally, spiral arterial endothelial cells were EPHB4 þ (Fig. 5, A1 and B1 ). Both of these features are typical of normal B6 implantation sites and suggest lymphocytes initiate spiral arterial changes that permit subsequent structural change. B6 splenocyte engraftment of pregnant alymphoid mice induced no obvious changes in expression of EFNB2 by trophoblast cells or in expression of EPHB4 by venules or trophoblasts (Fig. 5, C and D) .
EFNB2 Is Expressed by a Subset of uNK Cells
To address whether some or all uNK cells express EFNB2, DBA þ uNK cells and EFNB2 þ uNK cells were counted in serial sections. As shown in Fig. 6A , DBA þ uNK cell numbers increased significantly after gd6.5, peaked at gd8.5-10.5, then dropped at gd12.5. Many fewer uNK cells were EFNB2 þ , and these were most abundant at gd10.5. The proportion of EFNB2 þ cells among total uNK cells appeared to be stable (Fig. 6B) .
To establish whether EPHB2 expression is unique to a subset of uNK cells or shared with NK cells from other organs, NK cells and T cells from decidua, spleens, and livers of gd10.5 B6 mice were examined by flow cytometry (Fig. 7) . Using DX5 and CD3 to identify NK (DX5
and T cells (DX5
, we confirmed that decidua and liver are enriched in NK and NKT cells, wheras spleen is enriched in NKT and T cells (Fig. 7B, top panel) .
Most DX5
þ lymphocytes in liver do not express EFNB2 (Fig. 7A, middle panel) . Only a subset of ;10% of decidual DX5 þ cells express EFNB2 (Fig. 7A, top panel) . This subset was 40-fold more frequent than in liver and 20-fold more frequent than in spleen (Fig. 7A, bottom panel) . Most CD3 þ lymphocytes did not express EFNB2 (Fig. 7A, right panel) , but there was a minor elevation (,2-fold) in EFNB2 expression by uterine T cells compared with T cells from liver or spleen.
DISCUSSION
This study revealed dynamic changes in patterns of EFNB2 and EPHB4 expression at the maternal-fetal interface during mouse pregnancy. The four major findings are summarized in Fig. 8 and Supplemental Table 1 (available online at www. biolreprod.org). First was the unexpected finding that gd6.5-10.5 uNK cells express EFNB2 and that this expression is confined to a distinct NK cell subset not found in liver or spleen. Second was the demonstration that, in normal mice, EFNB2 þ spiral arteries shift from EPHB4 À to EPHB4 þ structures between gd10.5 and 12.5. This shift was accompanied by an increase in EPHB4 expression by uNK cells. Third was that the absence of uNK cells dramatically elevated stromal expression of both EFNB2 and EPHB4 and that this expression could be decreased by short-term lymphocyte transfer. Fourth was that dynamic changes in LYVE1 expression were dependent on gestational length but not the absence of uNK cells. These data suggest that the implantation site edema seen in alymphoid mice is likely not due to 3 ) and alymphoid (columns 2 and 4) mice at gd6.5 and 10.5. B6 embryo was in a more developed stage compared to that of alymphoid at gd6.5. In B6 mice, trophoblasts were prominently reactive with EFNB2 at gd6.5 (A), but rare trophoblasts of alymphoid mice were positive for EFNB2 (B). At gd10.5, trophoblast EFNB2 reactivity was down-regulated for both strains (C, D). Relative weak EPHB4 expressions appeared on matched implantation sites (E-H). Em, embryo; EC, ectoplacental cone; DB, decidual basalis; PL, placenta. Bar ¼100 lm.
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defective organization of transient decidual lymphatics. Rather, the edema is more likely to arise from ineffective pericyte and smooth muscle cell recruitment to nascent endothelial structures in developing decidua, due to the absence of uNK cells involved in EFNB2/EPHB4 signaling. We propose that expression of EFNB2 by uNK cells is key to their exclusive physical localization to arterial rather than to venous or lymphatic vessels. EFNB2 þ endothelia attract and promote interactions with EFNB2 þ cells, whereas EPHB4 þ endothelia repel EFNB2 þ cells. These actions are independent of cell type and, in implantation sites, would apply to endothelial progenitor cells [19] and to trophoblast cells [30] as well as to all types of immune cells. The attraction of uNK cells to early gestational mouse uterine arteries would place   FIG. 5. Expression of EFNB2 (A, A1, C)  and EPHB4 (B, B1, D) in gd10.5 implantation sites of alymphoid mice. Alymphoid mice were reconstituted with B6 spenocytes at gd6.5. Boxed areas are shown at higher magnification. EFNB2 and EPHB4 staining were found in the deep stroma of the DB next to myometrium and became the most reactive tissue. EFNB2 staining on spiral artery (SA) walls (A1) was reduced compared with nonengrafted mice (Fig. 2, E þ uNK cells to total DBA lectin þ lymphocytes on different days of gestation. From 6 to 16 independent assessments were conducted, and all data are expressed as mean 6 SD. *, P , 0.05. There were no significant differences in B.
MOUSE IMPLANTATION SITE EFNB2/EPHB4
these lymphocytes in locations where they could deliver very high, localized doses of cytokines, particularly IFNG [8] , to endothelial cells and to cells comprising arterial walls. Indeed, quantitative histology previously estimated that 25%-35% of uNK cells are perivascular, where they could act basally on endothelial cells or directly with vascular smooth muscle cells. A further 7% of all gd10.5 uNK cells are found within decidual vessel lumens [31] , where they could act apically on endothelial cells.
The transition of spiral arteries from an EFNB2 þ high state to an EFNB2 þ low state accompanied by a strong gain in EPHB4 has profound implications. First, this transition would be expected to reduce interactions with EFNB2 þ immune cells and EFNB2
þ trophoblasts and initiate repulsion of these cells. Second, this transition would imply the vessel had changed in function. In other tissues, arterial gain of EPHB4 is associated with a gain in shear force, as might be expected from midgestation demands for placental blood supply delivered though a spiral-shaped conduit. This transition is also seen in arteries supplying tumors [32] . It may be that the rapid growth of the placenta during its post-differentiation/maturation period provides a tumor-like stimulus for arterial endothelial cells. The apparent discontinuous change and insertion of EPHB4 þ endothelial cells into EFNB2 þ spiral arterial endothelium could serve as a highly regulated model for understanding potential proangiogenic functions of endothelial progenitor cells [33] and the roles of molecular switching in endothelium of vessels supporting tumors.
The role of endometrial lymphocytes appears to relate more to the down-regulation of EFNB2 and to its expression by appropriate cell types within arteries than to induction of EPHB4, since EPHB4 expression was only slightly delayed to gd12.5, but not blocked, in alymphoid mice. Regulation of induction of EPHB4 in midgestation spiral arteries may thus be 
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due to the endocrine environment or to the fetal-placental unit. The shift from EFNB2 þ to EPHB4 þ in uNK cells themselves seemed to occur slightly in advance of the same molecular transition in spiral arteries. This may be a further regulatory mechanism to terminate or down-regulate interactions between uNK cells and arterial vessels that have been set upon their modification process. Regulation of the EFNB2 to EPHB4 transition may be the same or different for lymphocytes and for spiral arteries. From gd8.5, uNK cell death is recognized [26] . This also reduces uNK cell interactions with the placenta's growing arterial support tree. It cannot be excluded that uNK cells must undergo the EFNB2 to EPHB4 transition as a step in their cell death process. Assembly of coexpressed EFNB2/ EPHB4 in the membrane of a single cell has been shown to have masking or inhibitory actions and to polarize the cell's responsiveness to external signals [34] .
The finding that EFNB2 þ NK cells are 20-to 40-fold more abundant in gd10.5 decidua than in spleen or liver supports the hypothesis that uNK cells have adopted specialized functions in implantation sites and emphasizes how poorly their lineage relationships are understood. The relationships between EFNB2 þ and EFNB2 À uNK cells are important to define. It is possible that the extracellular matrix or unique decidual cells or products support proangiogenic differentiation of a uNK subset and that all NK or all uNK cells can be induced to become EFNB2 þ
/EPHB4
þ expressing within an appropriate microenvironment. Alternately, expression of these proteins may distinguish cells that have homed from the periphery from those with uterine precursors or uNK cell subsets arising from other relationships. Understanding regulation of expression of this phenotype, which determines cell positioning, has clinical importance to pre-eclampsia and intrauterine growth restriction and to therapeutic implications for additional endometrial and nonuterine pathologies. The dramatic gain in EFNB2 and EPHB4 expression in deep decidual cells of pregnant alymphoid mice strongly implies that stromal cells in this region participate in and sense uNK cell recruitment and/or differentiation and have compensatory mechanisms to respond to aberrant implantation site development.
The dynamic changes in EFNB2 and EPHB4 expression seen in mouse trophoblasts are not unique. In human pregnancy, trophoblast EFNB2 and EPHB4 are significantly decreased with gestation stage and are involved in building functional placental structures [35] . Human cytotrophoblasts switch from venous (EPHB4 þ ) to arterial (EFNB2 þ ) molecular expression as they differentiate to become extravillous invasive trophoblasts [30] . This has been postulated to explain the unique association of human extravillous trophoblasts with arteries and not veins [13, 36] . Further, human cytotrophoblast xenografts in immune-deficient mice appear to induce lymphangiogenesis and arterial apoptosis [36] . Whether LYVE1, found on early mouse giant cells, directs vascular homing of trophoblasts or prevents it until LYVE1 downregulation permits EFNB2 þ trophoblasts to seek arteries awaits further study.
Human blood monocytes, some lymphocytes, and bone marrow stromal cells are reported to express EFNB2 [37, 38] . EFNB2 mRNA or protein has been associated with T but not B cells and is modified by the cytokine milieu [39] . Previously, Koopman et al. showed Efna2 and Efna4 mRNA was equally abundant in peripheral and decidual NK cells of different subjects [40] . To the best of our knowledge, the current study is the first report of EFNB2 protein expression by any NK cell. In mice, EFNB2 and its receptor are expressed on ;10% of splenic T cells, and EFNB2 ligation provides a co-stimulatory signal to T cells that enhances release of IFNG but not IL2 or IL4 [41] . A similar pathway may be important in implantation sites where uNK cells abundantly produce IFNG in the absence of IL2 [42] . Since EFNB2 and EPHB4 are key elements promoting cell migration, their novel expression by uNK cells defines an additional regulatory level to explain the distribution pattern of uNK cells within implantation sites beyond currently defined chemokine, selectin, and integrin pathways [15, 30, 43] .
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